CClinicalTrials.gg
Not yet recruitingNCT07576673Updated Jul 6, 2026

Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-Month RCT

An interventional study of Class V Restoration - Polofil and Class V Restoration - Stela in Carious Cervical Lesions, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 21 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
All
01

Study summary

The aim of the study is to compare and evaluate the clinical performance of a self cure composite system versus a highly filled flowable composite in the restoration of carious cervical lesions over an 18 months follow up period.

Read the detailed description

Examination and selection of patients will be done according to the inclusion and exclusion criteria. A class V cavity will be prepared after local anesthesia has been given. Followed by the placement of the restorative material according to the randomization sequence.

For the intervention: the primer will be applied first followed by filling of the cavity using self cure composite (Stella Automix or Stela Capsule, SDI Ltd, Australia). For the control group: etching of the cavity (Kulzer Gluma Etch, Kulzer GmbH, Germany) will be done followed by rinsing, drying, applying the bonding agent (Solobond M, Voco GmbH, Germany), curing, and lastly, applying the highly filled flowable composite (Polofil NHT flow, Voco Gmbh, Germany) and curing.

02

Conditions studied

  • Carious Cervical Lesions

Keywords

  • Class V
  • Cervical Carious Lesions
  • Self-cure Composite
  • Highly Filled Flowable Composite
  • Stela
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patient-related Criteria:

A) Inclusion Criteria:

  • Patients consulting in the outpatient clinic with cervical carious lesion.
  • Age between 21-45 years.
  • Males and females.

B) Exclusion Criteria:

  • Systemic disease or severe medical complication.
  • Allergy to any of the restorative materials.
  • Pregnancy.
  • Disabilities.
  • Heavy smoking; xerostomia.
  • Lack of compliance.
  • Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits.

Tooth-related Criteria:

A) Inclusion Criteria:

  • Small to moderate class V carious lesion.
  • Teeth are vital with no signs of irreversible pulpitis.
  • Caries cervical margins above the CEJ.
  • Well-formed and fully erupted in normal functional occlusion with natural antagonist.

B) Exclusion Criteria:

  • Deciduous teeth; as the study is targeting only permanent teeth.
  • Deep carious defects (close to the pulp, less than 1 mm distance).
  • Tooth hypersensitivity.
  • Teeth with previous restorations, which may add another variable to the study (type of old restorative material, extent of recurrent caries).
  • Heavy occlusion and occlusal contacts or history of bruxism.
  • Endodontically treated teeth.
  • Periapical pathology or signs of pulpal pathology.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Self-cure Bulk Fill Resin Composite (Stela Automix or Stela Capsule, SDI Limited, Australia)

    Procedure: Class V Restoration - Stela

  • Active comparator
    Highly Filled Flowable Composite (Polofil NHT flow, Voco GmbH, Germany)

    Procedure: Class V Restoration - Polofil

Interventions

  • ProcedureClass V Restoration - Polofil

    A class V cavity with 1 mm occlusal bevel will be prepared after administering local anesthesia. Rubber dam isolation will be done, , etching of the enamel (20-30 seconds) and dentin (15 seconds) using a 35% phosphoric acid etch (Kulzer Gluma Etch, Kulzer GmbH, Germany), then rinsing for 20 seconds followed by controlled drying of the cavity till it's slightly moist. Application of the bonding agent (Solobond M, Voco GmbH, Germany) using a disposable brush and leaving it to act for 30 seconds then an air jet will be used to disperse the bonding agent. Curing for 20 seconds will be done using a LED light curing unit with curing intensity 1200-3000 mw/cm2 (CuringPen-E, Changzhou Sifary Medical Technology Co., Ltd, China). Flowable composite (Polofil NHT flow, Voco GmbH, Germany) will be placed, adapted by gold plated applicator then light polymerized for 20 seconds using light emitting diode (LED) light curing unit.

  • ProcedureClass V Restoration - Stela

    A class V cavity with 1 mm occlusal bevel will be prepared after administrating local anesthesia followed by rubber dam isolation. Stela Primer (SDI Limited, Australia.) will be applied for 5 seconds on the cavity and the margins, then it will be gently dried with air for 2-3 seconds without light curing. The self-cure bulk fill resin composite (Stela Automix or Stela Capsule, SDI Limited, Australia) will be applied then sculpted using a gold-plated composite applicator (Lascod, Italy). Full polymerization will take place after 4 minutes.

06

What researchers measure

Primary outcomes

  1. Retention

    The restoration will be clinically assessed according to the modified USPHS criteria. Restoration will be given Alpha score when there is no loss of restoration. It will be given a Charlie score when there is loss of restoration and need for replacement.

    Time frame: 18 Months

Secondary outcomes

  1. Marginal Adaptation

    The restoration will be clinically assessed according to the modified USPHS criteria. It will be give an Alpha score when the restoration is closely adapted with no detectable margin. It will be given a Bravo score when there is a detectable marginal discrepancy, but it still clinically acceptable. It will be given a Charlie score when there is a marginal crevice that is clinically unacceptable.

    Time frame: 18 months

  2. Marginal Discoloration

    The restoration will be clinically assessed according to the modified USPHS criteria. It will be given an Alpha score when there is no discoloration between the tooth and the restoration. It will be given a Bravo score when there is superficial discoloration which can be polished away. It will be give a Charlie score when the discoloration has penetrated beyond the margin in pulpal direction.

    Time frame: 18 months

  3. Post-operative Sensitivity

    The restoration will be clinically assessed according to the modified USPHS criteria. It will be give an Alpha score when there is no post-operative sensitivity and a Charlie score when there is post-operative sensitivity.

    Time frame: 18 months

  4. Recurrent Caries

    The restoration will be clinically assessed according to the modified USPHS criteria. It will be given an Alpha score when there is no detectable recurrent caries and a Charlie score when recurrent caries is detected.

    Time frame: 18 months

  5. Surface Roughness

    The restoration will be clinically assessed according to the modified USPHS criteria. It will be given an Alpha score when there is no surface defect. It will be given a bravo score when there is minimal surface defect. It will be given a charlie score when there is a severe surface defect.

    Time frame: 18 months

  6. Color Match

    The restoration will be clinically assessed according to the modified USPHS criteria. It will be given an Alpha score when the restoration matches the color of the tooth. It will be give a Bravo score when there is an acceptable mismatch. It will be given a Charlie score when there is an unacceptable mismatch.

    Time frame: 18 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07576673
Lead sponsor
Cairo University
Responsible party
Abdelrahman Hamza Halim Hamza (MSc Candidate, Department of Restorative and Esthetic Dentistry, Faculty of Dentistry, Cairo University, Cairo University) — Principal investigator
First posted
May 8, 2026
Start date
Sep 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Jul 6, 2026

Study contacts

Abdelrahman Hamza, Bachelor of Science
Contact
abdelrahmanh.hamza@dentistry.cu.edu.eg
+20 1063330630

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion